A randomized controlled trial comparing a digitally delivered gut-directed hypnotherapy (GDH) program (Nerva) to an active control found that GDH significantly improved IBS symptoms and quality of life. Among 240 participants, 81% of those using the GDH program experienced a ≥50-point decrease in IBS symptom severity compared to 63% in the control group (P = 0.002). GDH also led to a greater reduction in pain (71% vs. 35%, P < 0.001) and quality-of-life improvements (P < 0.001). These findings support digital GDH as an effective and accessible alternative to in-person behavioral interventions for IBS management.
Trending
- Digital self-management programme for pain, fatigue and faecal incontinence in inflammatory bowel disease: cost-effectiveness analysis of the IBD-BOOST randomised controlled trial (BMJ)
- Clinicians Encouraged to ‘See C. diff Differently’ as Diagnostics, Resistance Patterns, and Therapeutic Tools Shift (GI & Endoscopy News)
- AGA, ACG Express Concerns About New American Cancer Society Recommendations (GI & Endoscopy News)
- In vitro development of the Autonomous Colonoscope Robot System (ACRS) for fully automated colonoscope insertion (Nature)
- Zobair Younossi, MD, on Global Consensus Recommendations for MASLD/MASH (HMP Global Learning Network )
- Recommending Blood Tests for CRC Without Guardrails Risks Confusion (MedPage Today)
- Gut Microbiome Could Remain Disrupted For Over a Decade After Polyp Removal (ScienceAlert)
- Why physician is not the same as provider (KevinMD)
